SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-087852 from Liminatus Pharma, Inc. (LIMN)

Liminatus Pharma, Inc.
Date: Aug. 9, 2024 · CIK: 0001971387 · Accession: 0001104659-24-087852

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-275409

Date
August 9, 2024
Author
/s/ Chris Kim
Form
CORRESP
Company
Liminatus Pharma, Inc.

Letter

Iris Parent Holding Corp.

6 Centerpointe Drive #625,

La Palma, California 90623

VIA EDGAR

August 9, 2024

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jimmy McNamara and Tim Buchmiller

Re: Iris Parent Holding Corp.

Acceleration Request for Registration Statement on Form S-4

File No. 333-275409

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Iris Parent Holding Corp. (the “Company”) hereby requests acceleration of the effective date of the above referenced Registration Statement to 5:00 p.m., Eastern Time, on August 9, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Loeb & Loeb LLP, request by telephone that such Registration Statement be declared effective.

Please contact Chauncey Lane of Holland & Knight LLP at (214) 969-1278, or by email at Chauncey.Lane@hklaw.com, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

[Signature Page Follows]

Sincerely,
/s/ Chris Kim

Show Raw Text
CORRESP
1
filename1.htm

Iris Parent Holding Corp.

6 Centerpointe Drive #625,

La Palma, California 90623

VIA EDGAR

August 9, 2024

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jimmy McNamara and Tim Buchmiller

 Re: Iris Parent Holding Corp.

Acceleration Request for Registration Statement
on Form S-4

File No. 333-275409

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Iris Parent Holding Corp. (the “Company”) hereby requests acceleration of the effective date
of the above referenced Registration Statement to 5:00 p.m., Eastern Time, on August 9, 2024, or as soon thereafter as practicable,
or at such other time as the Company or its outside counsel, Loeb & Loeb LLP, request by telephone that such Registration Statement
be declared effective.

Please contact Chauncey Lane of Holland &
Knight LLP at (214) 969-1278, or by email at Chauncey.Lane@hklaw.com, as soon as the Registration Statement has been declared effective,
or if you have any other questions or concerns regarding this matter.

[Signature Page Follows]

    Sincerely,

    /s/ Chris Kim

    Name: Chris Kim

    Title: Chief Executive Officer

Signature Page to Acceleration Request
Letter